Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-dependent protein kinase activity	PRKDC ATM	6.01e-05	3	90	2	GO:0004677
GeneOntologyMolecularFunction	histone H2AXS139 kinase activity	PRKDC ATM	6.01e-05	3	90	2	GO:0035979
GeneOntologyMolecularFunction	exoribonuclease II activity	HELZ2 ISG20	6.01e-05	3	90	2	GO:0008859
GeneOntologyMolecularFunction	histone H2AX kinase activity	PRKDC ATM	1.99e-04	5	90	2	GO:0141003
GeneOntologyMolecularFunction	3'-5' RNA helicase activity	YTHDC2 AQR	2.98e-04	6	90	2	GO:0034458
GeneOntologyMolecularFunction	RNA exonuclease activity, producing 5'-phosphomonoesters	HELZ2 ISG20 CPSF3	7.75e-04	40	90	3	GO:0016896
GeneOntologyMolecularFunction	transition metal ion binding	ADCY10 CYP4V2 ABCC8 CYP26A1 APOBEC3H PRND ZNF407 LHX5 CHD4 TRIM38 ZNF282 ZMYM3 RABGGTB ALOX15	8.43e-04	1189	90	14	GO:0046914
GeneOntologyMolecularFunction	U3 snoRNA binding	ISG20 PRKDC	1.08e-03	11	90	2	GO:0034511
GeneOntologyMolecularFunction	RNA exonuclease activity	HELZ2 ISG20 CPSF3	1.10e-03	45	90	3	GO:0004532
GeneOntologyBiologicalProcess	regionalization	TBC1D32 TDRKH HOXB4 HOXB7 IFT172 CYP26A1 IFT122 PRKDC ATM CFAP53 MED12	6.62e-06	478	89	11	GO:0003002
GeneOntologyBiologicalProcess	pattern specification process	TBC1D32 TDRKH HOXB4 HOXB7 IFT172 CYP26A1 IFT122 PRKDC ATM CFAP53 MED12	1.62e-05	526	89	11	GO:0007389
GeneOntologyBiologicalProcess	viral genome replication	APOBEC3H IFIT5 YTHDC2 ISG20 IFIT1 TRIM38	2.84e-05	137	89	6	GO:0019079
GeneOntologyBiologicalProcess	germ cell development	ADCY10 DNHD1 TDRKH ADRM1 POC1B YTHDC2 MAEL OSBP2 ATM CFAP53	4.32e-05	482	89	10	GO:0007281
GeneOntologyBiologicalProcess	regulation of viral genome replication	APOBEC3H IFIT5 ISG20 IFIT1 TRIM38	4.64e-05	91	89	5	GO:0045069
GeneOntologyBiologicalProcess	cellular process involved in reproduction in multicellular organism	ADCY10 DNHD1 TDRKH ADRM1 POC1B YTHDC2 MAEL OSBP2 ATM CFAP53	9.08e-05	527	89	10	GO:0022412
GeneOntologyBiologicalProcess	anterior/posterior pattern specification	TDRKH HOXB4 HOXB7 CYP26A1 PRKDC ATM MED12	9.70e-05	247	89	7	GO:0009952
GeneOntologyBiologicalProcess	negative regulation of viral genome replication	APOBEC3H IFIT5 ISG20 IFIT1	1.00e-04	56	89	4	GO:0045071
GeneOntologyBiologicalProcess	male gamete generation	ADCY10 DNHD1 TDRKH ADRM1 POC1B PRND YTHDC2 MAEL OSBP2 ATM USP9Y CFAP53	1.04e-04	762	89	12	GO:0048232
GeneOntologyBiologicalProcess	viral life cycle	WWP2 APOBEC3H IFIT5 YTHDC2 ISG20 CAV2 IFIT1 TRIM38	1.11e-04	340	89	8	GO:0019058
GeneOntologyBiologicalProcess	spermatid development	ADCY10 DNHD1 ADRM1 POC1B YTHDC2 OSBP2 CFAP53	1.40e-04	262	89	7	GO:0007286
GeneOntologyBiologicalProcess	immature B cell differentiation	PRKDC ATM SYVN1	1.67e-04	25	89	3	GO:0002327
GeneOntologyBiologicalProcess	spermatid differentiation	ADCY10 DNHD1 ADRM1 POC1B YTHDC2 OSBP2 CFAP53	1.76e-04	272	89	7	GO:0048515
GeneOntologyBiologicalProcess	negative regulation of cell cycle	SIN3B MBTPS1 INTS7 RBL1 MAP3K20 PPP2R3B YTHDC2 PRKDC ATM	1.77e-04	464	89	9	GO:0045786
GeneOntologyBiologicalProcess	negative regulation of mitotic cell cycle	MBTPS1 RBL1 MAP3K20 PPP2R3B YTHDC2 PRKDC ATM	2.20e-04	282	89	7	GO:0045930
GeneOntologyBiologicalProcess	microtubule-based movement	ADCY10 DNHD1 MAP1A IFT172 DLGAP5 POC1B DNAH2 IFT122 CFAP53	2.77e-04	493	89	9	GO:0007018
GeneOntologyBiologicalProcess	gamete generation	ADCY10 DNHD1 TDRKH ADRM1 POC1B PRND YTHDC2 MAEL OSBP2 ATM USP9Y CFAP53 SOS1	2.91e-04	982	89	13	GO:0007276
GeneOntologyBiologicalProcess	embryonic digit morphogenesis	TBC1D32 MAP3K20 IFT122 CPLANE1	2.96e-04	74	89	4	GO:0042733
GeneOntologyBiologicalProcess	DNA damage checkpoint signaling	MBTPS1 INTS7 MAP3K20 PRKDC ATM	3.08e-04	136	89	5	GO:0000077
GeneOntologyBiologicalProcess	protein localization to cilium	TBC1D32 IFT122 CPLANE1 CFAP53	3.45e-04	77	89	4	GO:0061512
GeneOntologyBiologicalProcess	regulation of mitotic cell cycle phase transition	MBTPS1 RBL1 DLGAP5 MAP3K20 PPP2R3B PRKDC ATM CPSF3	3.46e-04	402	89	8	GO:1901990
GeneOntologyBiologicalProcess	spermatogenesis	ADCY10 DNHD1 TDRKH ADRM1 POC1B PRND YTHDC2 MAEL OSBP2 USP9Y CFAP53	3.53e-04	744	89	11	GO:0007283
GeneOntologyBiologicalProcess	smoothened signaling pathway involved in dorsal/ventral neural tube patterning	TBC1D32 IFT122	3.81e-04	7	89	2	GO:0060831
GeneOntologyBiologicalProcess	regulation of cell cycle phase transition	MBTPS1 INTS7 RBL1 DLGAP5 MAP3K20 PPP2R3B PRKDC ATM CPSF3	3.86e-04	516	89	9	GO:1901987
GeneOntologyBiologicalProcess	negative regulation of cell cycle phase transition	MBTPS1 INTS7 RBL1 MAP3K20 PPP2R3B PRKDC ATM	3.97e-04	311	89	7	GO:1901988
GeneOntologyBiologicalProcess	heart development	TBC1D32 SIN3B SORBS2 IFT172 IFT122 PRKDC ATM ZFPM1 CPLANE1 MED12 SOS1	4.08e-04	757	89	11	GO:0007507
GeneOntologyBiologicalProcess	DNA integrity checkpoint signaling	MBTPS1 INTS7 MAP3K20 PRKDC ATM	4.14e-04	145	89	5	GO:0031570
GeneOntologyBiologicalProcess	regulation of viral life cycle	APOBEC3H IFIT5 ISG20 IFIT1 TRIM38	5.78e-04	156	89	5	GO:1903900
GeneOntologyCellularComponent	autosome	SIN3B MAEL	1.12e-04	4	91	2	GO:0030849
GeneOntologyCellularComponent	piP-body	TDRKH MAEL	1.86e-04	5	91	2	GO:0071547
GeneOntologyCellularComponent	ribonucleoprotein granule	TDRKH APOBEC3H HNRNPA3 HELZ2 YTHDC2 MAEL ISG20	2.59e-04	287	91	7	GO:0035770
GeneOntologyCellularComponent	pole plasm	TDRKH HELZ2 MAEL	2.69e-04	29	91	3	GO:0045495
GeneOntologyCellularComponent	germ plasm	TDRKH HELZ2 MAEL	2.69e-04	29	91	3	GO:0060293
GeneOntologyCellularComponent	P granule	TDRKH HELZ2 MAEL	2.69e-04	29	91	3	GO:0043186
GeneOntologyCellularComponent	inner dynein arm	DNHD1 DNAH2	8.25e-04	10	91	2	GO:0036156
Domain	TPR-like_helical_dom	ADCY10 TRANK1 IFT172 IFIT1B IFIT5 IFT122 PRKDC IFIT1 AAR2	2.22e-06	233	92	9	IPR011990
Domain	TPR_REGION	TRANK1 IFT172 IFIT1B DNAH2 IFIT5 PRKDC IFIT1	1.72e-05	165	92	7	PS50293
Domain	TPR	TRANK1 IFT172 IFIT1B DNAH2 IFIT5 PRKDC IFIT1	1.72e-05	165	92	7	PS50005
Domain	FATC	PRKDC ATM	2.38e-04	5	92	2	PF02260
Domain	FAT	PRKDC ATM	3.55e-04	6	92	2	PS51189
Domain	FATC	PRKDC ATM	3.55e-04	6	92	2	PS51190
Domain	FAT	PRKDC ATM	3.55e-04	6	92	2	PF02259
Domain	PIK-rel_kinase_FAT	PRKDC ATM	3.55e-04	6	92	2	IPR003151
Domain	FATC_dom	PRKDC ATM	3.55e-04	6	92	2	IPR003152
Domain	PIK_FAT	PRKDC ATM	3.55e-04	6	92	2	IPR014009
Domain	FATC	PRKDC ATM	3.55e-04	6	92	2	SM01343
Domain	Spectrin/alpha-actinin	SPTBN1 MCF2L2 PPL	5.17e-04	32	92	3	IPR018159
Domain	SPEC	SPTBN1 MCF2L2 PPL	5.17e-04	32	92	3	SM00150
Domain	-	ADCY10 TRANK1 IFIT1B IFIT5 IFT122 IFIT1	5.57e-04	207	92	6	1.25.40.10
Domain	TPR-contain_dom	TRANK1 IFIT1B IFIT5 PRKDC IFIT1	8.77e-04	150	92	5	IPR013026
Domain	-	ANKFY1 TRANK1 YTHDC2 ANKMY1 CAMTA2 ANKRD45	1.42e-03	248	92	6	1.25.40.20
Domain	Homeobox_antennapedia	HOXB4 HOXB7	1.53e-03	12	92	2	IPR017995
Domain	ANK_REPEAT	ANKFY1 TRANK1 YTHDC2 ANKMY1 CAMTA2 ANKRD45	1.57e-03	253	92	6	PS50088
Domain	Ankyrin_rpt-contain_dom	ANKFY1 TRANK1 YTHDC2 ANKMY1 CAMTA2 ANKRD45	1.60e-03	254	92	6	IPR020683
Domain	ANK_REP_REGION	ANKFY1 TRANK1 YTHDC2 ANKMY1 CAMTA2 ANKRD45	1.60e-03	254	92	6	PS50297
Domain	Ankyrin_rpt	ANKFY1 TRANK1 YTHDC2 ANKMY1 CAMTA2 ANKRD45	1.87e-03	262	92	6	IPR002110
Domain	WD40	IFT172 WDR87 POC1B PWP2 MIOS IFT122	2.10e-03	268	92	6	SM00320
Domain	Dynein_HC_stalk	DNHD1 DNAH2	2.10e-03	14	92	2	IPR024743
Domain	Dynein_heavy_dom-2	DNHD1 DNAH2	2.10e-03	14	92	2	IPR013602
Domain	DHC_N2	DNHD1 DNAH2	2.10e-03	14	92	2	PF08393
Domain	MT	DNHD1 DNAH2	2.10e-03	14	92	2	PF12777
Domain	WD40_repeat	IFT172 WDR87 POC1B PWP2 MIOS IFT122	2.26e-03	272	92	6	IPR001680
Domain	TPR_8	IFIT1B IFIT5 IFIT1	2.27e-03	53	92	3	PF13181
Domain	DHC_fam	DNHD1 DNAH2	2.42e-03	15	92	2	IPR026983
Domain	Dynein_heavy_dom	DNHD1 DNAH2	2.42e-03	15	92	2	IPR004273
Domain	Dynein_heavy	DNHD1 DNAH2	2.42e-03	15	92	2	PF03028
Domain	PI3/4_kinase_CS	PRKDC ATM	2.42e-03	15	92	2	IPR018936
Domain	WD_REPEATS_1	IFT172 WDR87 POC1B PWP2 MIOS IFT122	2.52e-03	278	92	6	PS00678
Domain	WD_REPEATS_2	IFT172 WDR87 POC1B PWP2 MIOS IFT122	2.57e-03	279	92	6	PS50082
Domain	WD_REPEATS_REGION	IFT172 WDR87 POC1B PWP2 MIOS IFT122	2.57e-03	279	92	6	PS50294
Domain	-	PRKDC ATM	2.75e-03	16	92	2	1.10.1070.11
Domain	PI3Kc	PRKDC ATM	2.75e-03	16	92	2	SM00146
Domain	PI3/4_kinase_cat_dom	PRKDC ATM	3.49e-03	18	92	2	IPR000403
Domain	PI3_PI4_kinase	PRKDC ATM	3.49e-03	18	92	2	PF00454
Domain	PI3_4_KINASE_3	PRKDC ATM	3.49e-03	18	92	2	PS50290
Domain	PI3_4_KINASE_1	PRKDC ATM	3.49e-03	18	92	2	PS00915
Domain	PI3_4_KINASE_2	PRKDC ATM	3.49e-03	18	92	2	PS00916
Domain	WD40_repeat_dom	IFT172 WDR87 POC1B PWP2 MIOS IFT122	3.49e-03	297	92	6	IPR017986
Domain	-	ADCY10 DNHD1 TRANK1 SBNO1 ABCC8 HELZ2 DNAH2 YTHDC2 CHD4 AQR	3.66e-03	746	92	10	3.40.50.300
Domain	TPR	TRANK1 IFIT1B IFIT5 IFIT1	3.80e-03	129	92	4	SM00028
Domain	TPR_repeat	TRANK1 IFIT1B IFIT5 IFIT1	4.23e-03	133	92	4	IPR019734
Domain	-	MAP1A CPSF3	4.30e-03	20	92	2	3.60.15.10
Domain	Metallo-B-lactamas	MAP1A CPSF3	4.30e-03	20	92	2	IPR001279
Domain	Homeobox_Antennapedia_CS	HOXB4 HOXB7	4.74e-03	21	92	2	IPR001827
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PASK SORBS2 SPTBN1 DLGAP5 HELZ2 YTHDC2 CHD4 ELK3 PRKDC ATM ZFPM1 ZMYM3 PPL SOS1	1.65e-08	774	92	14	15302935
Pubmed	The Interferon-Induced Exonuclease ISG20 Exerts Antiviral Activity through Upregulation of Type I Interferon Response Proteins.	IFIT1B ISG20 IFIT1	1.79e-08	3	92	3	30232164
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SPTBN1 MCM3AP PWP2 HNRNPA3 HELZ2 YTHDC2 CHD4 PRKDC ATM CPSF3 MED12 ZMYM3 AQR	1.84e-08	653	92	13	22586326
Pubmed	The protective role of Toll-like receptor 3 and type-I interferons in the pathophysiology of vein graft disease.	IFIT1B TLR3 IFIT1	1.78e-07	5	92	3	29879406
Pubmed	The broad-spectrum antiviral functions of IFIT and IFITM proteins.	IFIT1B IFIT5 IFIT1	3.56e-07	6	92	3	23237964
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SORBS2 MAP1A SPTBN1 HNRNPA3 HELZ2 MIOS CHD4 PRKDC ATM USP9Y CPSF3 MED12 ZMYM3 AQR	9.65e-07	1082	92	14	38697112
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MBTPS1 SORBS2 ANKFY1 IFT172 MCM3AP CAMTA2 SYVN1 ZMYM3 AQR	1.39e-06	407	92	9	12693553
Pubmed	Antiviral Protection via RdRP-Mediated Stable Activation of Innate Immunity.	IFIT1B TLR3 IFIT1	2.12e-06	10	92	3	26633895
Pubmed	KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population.	KIR2DS2 KIR2DL2	6.92e-06	2	92	2	22836042
Pubmed	DNA-PKcs and ATM modulate mitochondrial ADP-ATP exchange as an oxidative stress checkpoint mechanism.	PRKDC ATM	6.92e-06	2	92	2	36727301
Pubmed	Development of bis-ANS-based modified fluorescence titration assay for IFIT/RNA studies.	IFIT5 IFIT1	6.92e-06	2	92	2	32962861
Pubmed	2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo.	IFIT1B IFIT1	6.92e-06	2	92	2	22589727
Pubmed	Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development.	PRKDC ALOX15	6.92e-06	2	92	2	23437231
Pubmed	Mouse Ifit1b is a cap1-RNA-binding protein that inhibits mouse coronavirus translation and is regulated by complexing with Ifit1c.	IFIT1B IFIT1	6.92e-06	2	92	2	33454014
Pubmed	Synthetic lethality between mutation in Atm and DNA-PK(cs) during murine embryogenesis.	PRKDC ATM	6.92e-06	2	92	2	11231155
Pubmed	Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation.	PRKDC ATM	6.92e-06	2	92	2	10464290
Pubmed	Regulation of the DNA Damage Response by DNA-PKcs Inhibitory Phosphorylation of ATM.	PRKDC ATM	6.92e-06	2	92	2	27939942
Pubmed	KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.	KIR2DS2 KIR2DL2	6.92e-06	2	92	2	30689576
Pubmed	Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients.	KIR2DS2 KIR2DL2	6.92e-06	2	92	2	32961633
Pubmed	Mael is essential for cancer cell survival and tumorigenesis through protection of genetic integrity.	MAEL ATM	6.92e-06	2	92	2	27926513
Pubmed	ATM mediated phosphorylation of CHD4 contributes to genome maintenance.	CHD4 ATM	6.92e-06	2	92	2	21219611
Pubmed	The DNA damage response kinases DNA-dependent protein kinase (DNA-PK) and ataxia telangiectasia mutated (ATM) Are stimulated by bulky adduct-containing DNA.	PRKDC ATM	6.92e-06	2	92	2	21487018
Pubmed	Activation of DNA Damage Response Pathways during Lytic Replication of KSHV.	PRKDC ATM	6.92e-06	2	92	2	26057167
Pubmed	Deciphering the role of distinct DNA-PK phosphorylations at collapsed replication forks.	PRKDC ATM	6.92e-06	2	92	2	32674014
Pubmed	Structural basis for viral 5'-PPP-RNA recognition by human IFIT proteins.	IFIT5 IFIT1	6.92e-06	2	92	2	23334420
Pubmed	The KIR2DS2/DL2 genotype is associated with adult persistent/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms.	KIR2DS2 KIR2DL2	6.92e-06	2	92	2	22024796
Pubmed	Killer cell immunoglobulin-like receptor polymorphisms in HLA-identical kidney transplant recipients: lack of 2DL2 and 2DS2 may be associated with poor graft function.	KIR2DS2 KIR2DL2	6.92e-06	2	92	2	17445184
Pubmed	Overexpression of IFIT1 protects against LPS-induced acute lung injury via regulating CCL5-p65NF-κB signaling.	IFIT1B IFIT1	6.92e-06	2	92	2	36446235
Pubmed	KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients.	KIR2DS2 KIR2DL2	6.92e-06	2	92	2	27251940
Pubmed	Identification and validation of Ifit1 as an important innate immune bottleneck.	IFIT1B IFIT1	6.92e-06	2	92	2	22745654
Pubmed	Ifit1 inhibits Japanese encephalitis virus replication through binding to 5' capped 2'-O unmethylated RNA.	IFIT1B IFIT1	6.92e-06	2	92	2	23824812
Pubmed	High prevalence of HHV8 infection and specific killer cell immunoglobulin-like receptors allotypes in Sardinian patients with type 2 diabetes mellitus.	KIR2DS2 KIR2DL2	6.92e-06	2	92	2	24122895
Pubmed	Ataxia telangiectasia-mutated protein and DNA-dependent protein kinase have complementary V(D)J recombination functions.	PRKDC ATM	6.92e-06	2	92	2	21245310
Pubmed	Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.	KIR2DS2 KIR2DL2	6.92e-06	2	92	2	26202659
Pubmed	The association between expression of IFIT1 in podocytes of MRL/lpr mice and the renal pathological changes it causes: An animal study.	IFIT1B IFIT1	6.92e-06	2	92	2	27823966
Pubmed	A viral RNA structural element alters host recognition of nonself RNA.	IFIT1B IFIT1	6.92e-06	2	92	2	24482115
Pubmed	The molecular causes of low ATM protein expression in breast carcinoma; promoter methylation and levels of the catalytic subunit of DNA-dependent protein kinase.	PRKDC ATM	6.92e-06	2	92	2	17593081
Pubmed	DNA double-strand break formation upon UV-induced replication stress activates ATM and DNA-PKcs kinases.	PRKDC ATM	6.92e-06	2	92	2	19071136
Pubmed	Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA.	IFIT1B IFIT1	6.92e-06	2	92	2	24098121
Pubmed	Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation.	PRKDC ATM	6.92e-06	2	92	2	20617180
Pubmed	Evolution-guided functional analyses reveal diverse antiviral specificities encoded by IFIT1 genes in mammals.	IFIT1B IFIT1	6.92e-06	2	92	2	27240734
Pubmed	Roles of DNA-dependent protein kinase and ATM in cell-cycle-dependent radiation sensitivity in human cells.	PRKDC ATM	6.92e-06	2	92	2	12065055
Pubmed	IFIT1 Differentially Interferes with Translation and Replication of Alphavirus Genomes and Promotes Induction of Type I Interferon.	IFIT1B IFIT1	6.92e-06	2	92	2	25927359
Pubmed	IFIT1 Exerts Opposing Regulatory Effects on the Inflammatory and Interferon Gene Programs in LPS-Activated Human Macrophages.	IFIT1B IFIT1	6.92e-06	2	92	2	30282041
Pubmed	15-lipoxygenase-1 activates tumor suppressor p53 independent of enzymatic activity.	PRKDC ALOX15	6.92e-06	2	92	2	18785202
Pubmed	Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break.	PRKDC ATM	6.92e-06	2	92	2	17189255
Pubmed	Association of killer cell immunoglobulin-like receptors with scleroderma.	KIR2DS2 KIR2DL2	6.92e-06	2	92	2	15146426
Pubmed	Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia.	KIR2DS2 KIR2DL2	6.92e-06	2	92	2	25636579
Pubmed	Human and Murine IFIT1 Proteins Do Not Restrict Infection of Negative-Sense RNA Viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae Families.	IFIT1B IFIT1	6.92e-06	2	92	2	26157117
Pubmed	AIF-mediated caspase-independent necroptosis requires ATM and DNA-PK-induced histone H2AX Ser139 phosphorylation.	PRKDC ATM	6.92e-06	2	92	2	22972376
Pubmed	G(2)-M phase-correlative bystander effects are co-mediated by DNA-PKcs and ATM after carbon ion irradiation.	PRKDC ATM	6.92e-06	2	92	2	26774662
Pubmed	DNA protein kinase-dependent G2 checkpoint revealed following knockdown of ataxia-telangiectasia mutated in human mammary epithelial cells.	PRKDC ATM	6.92e-06	2	92	2	18172300
Pubmed	[Correlation analysis between killer cell immunoglobulin-like receptor gene polymorphism and primary biliary cirrhosis].	KIR2DS2 KIR2DL2	6.92e-06	2	92	2	25575065
Pubmed	Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma.	KIR2DS2 KIR2DL2	6.92e-06	2	92	2	35154153
Pubmed	Ifit1 Protects Against Lipopolysaccharide and D-galactosamine-Induced Fatal Hepatitis by Inhibiting Activation of the JNK Pathway.	IFIT1B IFIT1	6.92e-06	2	92	2	26459629
Pubmed	SORBS2 and TLR3 induce premature senescence in primary human fibroblasts and keratinocytes.	SORBS2 TLR3	6.92e-06	2	92	2	24165198
Pubmed	Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection.	IFIT1B TLR3 IFIT1	7.96e-06	15	92	3	24362933
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ANKFY1 SPTBN1 MCM3AP DLGAP5 HNRNPA3 MAP3K20 CHD4 PRKDC ECM1 CPSF3 MED12 ZMYM3 AQR AAR2	1.26e-05	1353	92	14	29467282
Pubmed	IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA.	IFIT1B HNRNPA3 IFIT5 IFIT1	1.74e-05	58	92	4	21642987
Pubmed	Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein.	RBL1 PPP2R3B	2.07e-05	3	92	2	9927208
Pubmed	Evaluation of the genetic diversity of KIR genes in patients with endometrial cancer.	KIR2DS2 KIR2DL2	2.07e-05	3	92	2	38387251
Pubmed	The SAGA Deubiquitination Module Promotes DNA Repair and Class Switch Recombination through ATM and DNAPK-Mediated γH2AX Formation.	PRKDC ATM	2.07e-05	3	92	2	27160905
Pubmed	Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.	PRKDC ATM	2.07e-05	3	92	2	9766667
Pubmed	TRIM38 Negatively Regulates TLR3/4-Mediated Innate Immune and Inflammatory Responses by Two Sequential and Distinct Mechanisms.	TLR3 TRIM38	2.07e-05	3	92	2	26392463
Pubmed	Structure, chromosome localization, and regulation of expression of the interferon-regulated mouse Ifi54/Ifi56 gene family.	IFIT1B IFIT1	2.07e-05	3	92	2	7896268
Pubmed	Identification and characterization of FUS/TLS as a new target of ATM.	PRKDC ATM	2.07e-05	3	92	2	18620545
Pubmed	Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.	KIR2DS2 KIR2DL2	2.07e-05	3	92	2	20082621
Pubmed	Severe hypoxia increases expression of ATM and DNA-PKcs and it increases their activities through Src and AMPK signaling pathways.	PRKDC ATM	2.07e-05	3	92	2	30224064
Pubmed	[Potentials of DNA-PKcs, Ku80, and ATM in enhancing radiosensitivity of cervical carcinoma cells].	PRKDC ATM	2.07e-05	3	92	2	17626748
Pubmed	DNA-PK and ATM phosphorylation sites in XLF/Cernunnos are not required for repair of DNA double strand breaks.	PRKDC ATM	2.07e-05	3	92	2	18644470
Pubmed	Tagging single nucleotide polymorphisms in phosphoinositide-3-kinase-related protein kinase genes involved in DNA damage "checkpoints" and lung cancer susceptibility.	PRKDC ATM	2.07e-05	3	92	2	18451257
Pubmed	Ionizing radiation-induced XRCC4 phosphorylation is mediated through ATM in addition to DNA-PK.	PRKDC ATM	2.07e-05	3	92	2	25391321
Pubmed	Functional intersection of ATM and DNA-dependent protein kinase catalytic subunit in coding end joining during V(D)J recombination.	PRKDC ATM	2.07e-05	3	92	2	23836881
Pubmed	DNA Damage Signaling Is Required for Replication of Human Bocavirus 1 DNA in Dividing HEK293 Cells.	PRKDC ATM	2.07e-05	3	92	2	27733644
Pubmed	Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.	KIR2DS2 KIR2DL2	2.07e-05	3	92	2	30696053
Pubmed	Arthritogenic properties of double-stranded (viral) RNA.	TLR3 PRKDC	2.07e-05	3	92	2	15100310
Pubmed	GANP regulates the choice of DNA repair pathway by DNA-PKcs interaction in AID-dependent IgV region diversification.	MCM3AP PRKDC	2.07e-05	3	92	2	24808370
Pubmed	Mouse p56 blocks a distinct function of eukaryotic initiation factor 3 in translation initiation.	IFIT1B IFIT1	2.07e-05	3	92	2	15561726
Pubmed	Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.	KIR2DS2 KIR2DL2	2.07e-05	3	92	2	19877200
Pubmed	Dynamic change of histone H2AX phosphorylation independent of ATM and DNA-PK in mouse skin in situ.	PRKDC ATM	2.07e-05	3	92	2	17923115
Pubmed	Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells.	PRKDC ATM	2.07e-05	3	92	2	19444312
Pubmed	DNA damage, metabolism and aging in pro-inflammatory T cells: Rheumatoid arthritis as a model system.	PRKDC ATM	2.07e-05	3	92	2	29101015
Pubmed	Complex H2AX phosphorylation patterns by multiple kinases including ATM and DNA-PK in human cells exposed to ionizing radiation and treated with kinase inhibitors.	PRKDC ATM	2.07e-05	3	92	2	15389585
Pubmed	DNA-PKcs and ATM epistatically suppress DNA end resection and hyperactivation of ATR-dependent G2-checkpoint in S-phase irradiated cells.	PRKDC ATM	2.07e-05	3	92	2	31601897
Pubmed	Ataxia telangiectasia mutated (Atm) and DNA-PKcs kinases have overlapping activities during chromosomal signal joint formation.	PRKDC ATM	2.07e-05	3	92	2	21245316
Pubmed	TRIM38 negatively regulates TLR3-mediated IFN-β signaling by targeting TRIF for degradation.	TLR3 TRIM38	2.07e-05	3	92	2	23056470
Pubmed	ISG56 is involved in CXCL10 expression induced by TLR3 signaling in BEAS-2B bronchial epithelial cells.	TLR3 IFIT1	2.07e-05	3	92	2	32363951
Pubmed	Novel characteristics of the function and induction of murine p56 family proteins.	IFIT1B IFIT1	2.07e-05	3	92	2	18768971
Pubmed	Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) accelerates osteoclast formation by regulating signal transducer and activator of transcription 3 (STAT3) signalling.	IFIT1B IFIT1	2.07e-05	3	92	2	35034537
Pubmed	Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy.	PRKDC ATM	2.07e-05	3	92	2	25205036
Pubmed	The interaction between interferon-induced protein with tetratricopeptide repeats-1 and eukaryotic elongation factor-1A.	IFIT1B IFIT1	2.07e-05	3	92	2	19856081
Pubmed	ATM phosphorylates histone H2AX in response to DNA double-strand breaks.	PRKDC ATM	2.07e-05	3	92	2	11571274
Pubmed	Radiation-dose-dependent functional synergisms between ATM, ATR and DNA-PKcs in checkpoint control and resection in G2-phase.	PRKDC ATM	2.07e-05	3	92	2	31164689
Pubmed	Cross-species genomic and epigenomic landscape of retinoblastoma.	RBL1 PRKDC	2.07e-05	3	92	2	23765217
Pubmed	Tissue-specific DNA-PK-dependent H2AX phosphorylation and gamma-H2AX elimination after X-irradiation in vivo.	PRKDC ATM	2.07e-05	3	92	2	18755145
Pubmed	Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis.	KIR2DS2 KIR2DL2	2.07e-05	3	92	2	22960345
Pubmed	The FATC domains of PIKK proteins are functionally equivalent and participate in the Tip60-dependent activation of DNA-PKcs and ATM.	PRKDC ATM	2.07e-05	3	92	2	16603769
Pubmed	Perturbations in ataxia telangiectasia mutant signaling pathways after drug-induced acute liver failure and their reversal during rescue of animals by cell therapy.	PRKDC ATM	2.07e-05	3	92	2	21224054
Pubmed	Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients.	KIR2DS2 KIR2DL2	2.07e-05	3	92	2	23380384
Pubmed	Phosphorylation of polynucleotide kinase/ phosphatase by DNA-dependent protein kinase and ataxia-telangiectasia mutated regulates its association with sites of DNA damage.	PRKDC ATM	2.07e-05	3	92	2	21824916
Interaction	DCLRE1C interactions	PASK AKAP11 PRKDC ATM USP9Y	1.49e-06	43	92	5	int:DCLRE1C
Interaction	IFIT1B interactions	MAP1A IFIT1B IFIT1	5.07e-06	8	92	3	int:IFIT1B
Cytoband	10q23.31	IFIT1B IFIT5 IFIT1	4.45e-05	34	92	3	10q23.31
Cytoband	Ensembl 112 genes in cytogenetic band chr10q23	CYP26A1 IFIT1B IFIT5 IFIT1	6.59e-04	195	92	4	chr10q23
GeneFamily	UPF1 like RNA helicases	HELZ2 AQR	6.65e-04	11	64	2	1169
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TRANK1 IFIT1B IFIT5 IFIT1	7.35e-04	115	64	4	769
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS2 KIR2DL2	1.82e-03	18	64	2	620
GeneFamily	WD repeat domain containing	IFT172 WDR87 POC1B PWP2 IFT122	2.34e-03	262	64	5	362
GeneFamily	Intraflagellar transport proteins\|Tetratricopeptide repeat domain containing	IFT172 IFT122	3.24e-03	24	64	2	615
Coexpression	GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	CYP4V2 MBTPS1 RBL1 SPTBN1 TLR3 AKAP11 YTHDC2 TMCC3	5.17e-07	199	92	8	M8639
Coexpression	GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN	TRANK1 IFIT5 CHD4 ISG20 IFIT1 TRIM38 PPL	6.01e-06	196	92	7	M9590
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN	ANKFY1 TRANK1 HELZ2 IFIT5 ISG20 IFIT1 SOS1	6.43e-06	198	92	7	M4264
Coexpression	GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN	SPTBN1 MAP3K20 ATM ECM1 ZNF692 ZNF282 PPL	6.87e-06	200	92	7	M8081
Coexpression	GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	ANKFY1 TRANK1 TLR3 IFIT5 ISG20 IFIT1 TRIM38	6.87e-06	200	92	7	M3279
Coexpression	GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	ANKFY1 TRANK1 TLR3 IFIT5 ISG20 IFIT1 TRIM38	6.87e-06	200	92	7	M8967
Coexpression	GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN	ANKFY1 TRANK1 TLR3 IFIT5 ISG20 IFIT1 TRIM38	6.87e-06	200	92	7	M9570
Coexpression	GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN	ZNF7 TRANK1 TLR3 IFIT5 ISG20 IFIT1 TRIM38	6.87e-06	200	92	7	M9576
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	HOXB7 ABCC8 IFIT1B TLR3 HELZ2 IFIT1 MMD	1.95e-05	235	92	7	MM978
Coexpression	XIE_ST_HSC_S1PR3_OE_UP	HELZ2 IFIT5 ISG20 CAV2 ANKRD45 IFIT1	5.54e-05	189	92	6	M41755
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN	ADCY10 TRANK1 HELZ2 IFIT5 IFIT1 TMCC3	6.58e-05	195	92	6	M4279
Coexpression	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP	PASK TDRKH HOXB7 PRND CAV2 KIR2DL2	6.77e-05	196	92	6	M4999
Coexpression	GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP	ANKFY1 TRANK1 HELZ2 IFIT5 IFIT1 TRIM38	6.96e-05	197	92	6	M7543
Coexpression	GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN	TRANK1 TLR3 IFIT5 ISG20 IFIT1 TRIM38	7.16e-05	198	92	6	M8969
Coexpression	GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	SPTBN1 IFIT1B HELZ2 ELK3 CAMTA2 IFIT1	7.36e-05	199	92	6	M7451
Coexpression	GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN	IFIT1B TLR3 HELZ2 MIOS ISG20 IFIT1	7.36e-05	199	92	6	M7332
Coexpression	GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	ANKFY1 TLR3 IFIT5 ISG20 IFIT1 TRIM38	7.57e-05	200	92	6	M7618
Coexpression	GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN	TRANK1 TLR3 IFIT5 ISG20 IFIT1 TRIM38	7.57e-05	200	92	6	M9586
Coexpression	GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN	TRANK1 TLR3 IFIT5 ISG20 IFIT1 TRIM38	7.57e-05	200	92	6	M9588
Coexpression	GSE42021_TREG_VS_TCONV_PLN_UP	TRANK1 TLR3 IFIT5 ISG20 IFIT1 TRIM38	7.57e-05	200	92	6	M9572
Coexpression	GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	ANKFY1 RBL1 IFIT1B TLR3 HELZ2 ISG20	7.57e-05	200	92	6	M9020
Coexpression	BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP	TRANK1 TLR3 HELZ2 IFIT5 IFIT1 TRIM38	8.44e-05	204	92	6	M34006
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	HOXB7 ABCC8 IFIT1B TLR3 HELZ2 MMD	1.21e-04	218	92	6	M1099
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	AKAP11 YTHDC2 MAEL PRKDC ATM CPLANE1	9.51e-06	115	90	6	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRANK1 HELZ2 IFIT5 YTHDC2 ANKRD45 IFIT1 TRIM38	4.51e-08	163	91	7	d005115aa1e1458b51de7eb719794617a4168608
ToppCell	CV-Mild-1\|CV / Virus stimulation, Condition and Cluster	TRANK1 HELZ2 IFIT5 ISG20 KIR2DL2 IFIT1 TRIM38	1.70e-07	198	91	7	4b078714c49e7befb7b113d72485e712236d35fa
ToppCell	distal-3-Hematologic-Platelet/Megakaryocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MAP1A IFT172 DNAH2 ANKRD45 CFAP53 ALOX15 DRC3	1.82e-07	200	91	7	f5f5a8b0e4d802d95dc42646dd5e7d7daaad72b4
ToppCell	MS-CD4-antiviral_CD4\|MS / Condition, Cell_class and T cell subcluster	ADCY10 PASK HELZ2 IFIT5 ISG20 IFIT1	7.08e-07	152	91	6	b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee
ToppCell	Severe-CD4+_T_activated\|Severe / Disease group and Cell class	TRANK1 TLR3 HELZ2 IFIT5 ISG20 IFIT1	1.72e-06	177	91	6	a08f170f1143fcdd7d0842a54d9b807a4548f8b7
ToppCell	T_cells-ISG-high_CD4+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	TRANK1 HELZ2 IFIT5 ISG20 IFIT1 TRIM38	1.84e-06	179	91	6	af35ef8a7768cee0c2af0590e5bec35cee6a4714
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	TRANK1 HELZ2 IFIT5 ISG20 IFIT1 TRIM38	2.09e-06	183	91	6	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	T_cells-ISG-high_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	ANKFY1 TRANK1 HELZ2 IFIT5 ISG20 IFIT1	2.44e-06	188	91	6	6f8946d4710f6e32c937213f99b790b098b8819c
ToppCell	Calu_3-infected-SARSCoV2\|infected / Cell line, Condition and Strain	TRANK1 HELZ2 IFIT5 ISG20 IFIT1 TRIM38	2.67e-06	191	91	6	2da876d26f37a00dbdf1ee79d724306e8b20f304
ToppCell	B_cells-ISG-high_B_cells\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	ANKFY1 TRANK1 HELZ2 IFIT5 ISG20 IFIT1	3.01e-06	195	91	6	b64d9e1a8834401b4dc501566546647754ae21fc
ToppCell	mild-Myeloid-Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TRANK1 HELZ2 IFIT5 ISG20 IFIT1 TRIM38	3.10e-06	196	91	6	ded44b38ea489946e9eedfe752b5a9fde9149c16
ToppCell	Mild-CD4+_T_activated\|Mild / Disease group and Cell class	TRANK1 HELZ2 IFIT5 ISG20 IFIT1 TRIM38	3.10e-06	196	91	6	daa1c3322d81e649161e889e1d78451d2d425d09
ToppCell	Mild-CD8+_T_activated\|World / Disease group and Cell class	TRANK1 HELZ2 IFIT5 ISG20 IFIT1 TRIM38	3.10e-06	196	91	6	79632190e44fcef9d7c11d9b9e37f2ebf0e6e255
ToppCell	Mild-CD4+_T_activated\|World / Disease group and Cell class	TRANK1 HELZ2 IFIT5 ISG20 IFIT1 TRIM38	3.10e-06	196	91	6	417b4fc2e4388f34c410576131b02936f93e46b6
ToppCell	severe-Myeloid-Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TRANK1 HELZ2 IFIT5 ISG20 IFIT1 TRIM38	3.19e-06	197	91	6	c8a90d82170cf20e14aebecddcf7cc0ca56cda87
ToppCell	distal-Hematologic-Platelet/Megakaryocyte-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MAP1A IFT172 ANKRD45 CFAP53 ALOX15 DRC3	3.19e-06	197	91	6	751ffb8792058384079ebfe94872b3525f1aea84
ToppCell	distal-Hematologic-Platelet/Megakaryocyte\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MAP1A IFT172 ANKRD45 CFAP53 ALOX15 DRC3	3.19e-06	197	91	6	e28b1b154d9588dce07c123b36f7f01fa90a5fc1
ToppCell	VE-CD4-antiviral_CD4\|VE / Condition, Cell_class and T cell subcluster	PASK TRANK1 HELZ2 IFIT5 ISG20 IFIT1	3.39e-06	199	91	6	056a0538ca5e825ae6195b4c76c208708a014533
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	TRANK1 SPTBN1 HELZ2 IFIT5 USP9Y IFIT1	3.48e-06	200	91	6	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CYP4V2 RBL1 ZNF407 ECM1 IFIT1	1.02e-05	140	91	5	0e1e9281de87df178ac41ed6b697b4fa09be2749
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma\|TCGA-Bladder / Sample_Type by Project: Shred V9	HOXB4 HOXB7 HID1 ZFPM1 ZNF692	1.83e-05	158	91	5	dc559503bab3ec1b9ea54ef2e896d1be33e5344c
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	SIN3B IFT172 ANKMY1 CHD4 CPLANE1	2.32e-05	166	91	5	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IFT172 CYP26A1 DLGAP5 ALOX15 DRC3	2.60e-05	170	91	5	7534ac69ca3a378df78d61c284e89bc96a71a4a8
ToppCell	IIH-CD8-naive_CD4\|IIH / Condition, Cell_class and T cell subcluster	PASK INTS7 MCF2L2 ANKMY1 FCHO1	2.82e-05	173	91	5	4f2843371d18af766c1892529ce286f56c956fde
ToppCell	Severe-CD4+_T_activated\|World / Disease group and Cell class	TRANK1 TLR3 HELZ2 ISG20 IFIT1	3.24e-05	178	91	5	ef6111238703579a34bd6948bd9d4ca6b7e16063
ToppCell	droplet-Heart-4Chambers-21m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRND IFT122 ELK3 CAV2 MMD	3.60e-05	182	91	5	b1c1bb1b80c65dea2558051fd5953c1c4a251c1e
ToppCell	B_cells-ISG-high_B_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	TRANK1 HELZ2 IFIT5 ISG20 IFIT1	3.69e-05	183	91	5	dc2b00e920efa1dcc2a6265cd1024e3249c9974f
ToppCell	droplet-Heart-4Chambers-21m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRND IFT122 ELK3 CAV2 MMD	3.69e-05	183	91	5	29defb21458bc43d22ca5e4d08218db45aaa1add
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRANK1 IFIT5 ISG20 IFIT1 TRIM38	3.89e-05	185	91	5	f30fb9d75cdb757b206312992aaf7485bc900f96
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HOXB7 SPTBN1 ELK3 CAV2 TMCC3	4.20e-05	188	91	5	05de6677f9bb4b00fed47f4b72f4a2cd507cb0f2
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HOXB7 SPTBN1 ELK3 CAV2 TMCC3	4.31e-05	189	91	5	8ced0381ea042ba47680a02b617a2368fa2c54c8
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HOXB7 SPTBN1 ELK3 CAV2 TMCC3	4.31e-05	189	91	5	403a82bb416aed13b9d31411ad17bdc4ce2a95fb
ToppCell	Mild/Remission-B_activate-7\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TRANK1 HELZ2 IFIT5 ISG20 IFIT1	4.53e-05	191	91	5	382686d62f7b8576c44bb9726a4e10dc26fd348e
ToppCell	PBMC-Severe-Hematopoietic\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MAP1A IFIT1B OSBP2 CAV2 MMD	4.64e-05	192	91	5	68d0bf6249a24d23cb1b0be434bced2ff2d0f2b4
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ADCY10 SORBS2 MAP3K20 CAV2 ECM1	4.64e-05	192	91	5	fee99ca7e658963acf968aa724ef8c96cfc00a5d
ToppCell	COVID-19_Moderate-CD4+_T_activated\|COVID-19_Moderate / disease group, cell group and cell class	PASK HELZ2 IFIT5 ISG20 IFIT1	4.64e-05	192	91	5	7a81652406332afd03a9b3b529e9b5e6c0b54c28
ToppCell	PBMC-Severe-Hematopoietic\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MAP1A IFIT1B OSBP2 CAV2 MMD	4.64e-05	192	91	5	3b75fe82018bb259b02bfaee96b310f4d6df0350
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP1A IFT172 ANKMY1 CFAP53 ALOX15	4.64e-05	192	91	5	03acd4a26b986e34eee608747347791122f1aa52
ToppCell	BAL-Mild\|BAL / Compartment, Disease Groups and Clusters	TRANK1 HELZ2 IFIT5 ISG20 IFIT1	4.64e-05	192	91	5	1a6cbf014d3f7a3fb6f53adab078c4742e7137de
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP1A IFT172 ANKMY1 CFAP53 ALOX15	4.64e-05	192	91	5	31c6046589e2fbb0486fd044c5b128099d37872f
ToppCell	COVID-19_Moderate-CD4+_T_activated\|World / disease group, cell group and cell class	PASK HELZ2 IFIT5 ISG20 IFIT1	4.76e-05	193	91	5	c2a2a2c14a7085690262db5c2a70e38db67dee18
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH2 ANKRD45 CPLANE1 ALOX15 DRC3	4.76e-05	193	91	5	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	IPF-Endothelial-VE_Venous\|IPF / Disease state, Lineage and Cell class	SORBS2 NALF1 ABCC8 SPTBN1 CAV2	4.76e-05	193	91	5	29a655fa80feaabe846c90a28363b037e22d24ae
ToppCell	IPF-Endothelial-VE_Venous\|World / Disease state, Lineage and Cell class	SORBS2 NALF1 ABCC8 SPTBN1 CAV2	4.76e-05	193	91	5	ef66a46e7ab44fcc4005a23416e6da478a4cce37
ToppCell	Mild/Remission-B_activate-7\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TRANK1 HELZ2 IFIT5 ISG20 IFIT1	4.87e-05	194	91	5	01c97543972159a9468272da06e7e611e2c21fae
ToppCell	control-Myeloid-Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HELZ2 IFIT5 ISG20 IFIT1 TRIM38	4.87e-05	194	91	5	267e213e8efe53aadfe553a2ca010a0e3b4b8939
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A DNAH2 CFAP53 ALOX15 DRC3	4.99e-05	195	91	5	649fd2336e963f6a150d182a53ad5dd838ca80b1
ToppCell	COVID-19_Moderate-CD8+_T_activated\|World / disease group, cell group and cell class	TRANK1 HELZ2 IFIT5 ISG20 IFIT1	4.99e-05	195	91	5	070c5d3bdbd4ea54a579c01c37fb99bcf823982e
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A DNAH2 CFAP53 ALOX15 DRC3	4.99e-05	195	91	5	129ad5f4253ecb1a8477cc38773e6e91ea9570b0
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A DNAH2 CFAP53 ALOX15 DRC3	4.99e-05	195	91	5	3e70ee987d66d450062d5df3d7c733ccc7344470
ToppCell	COVID-19-Epithelial-Ciliated_cells\|Epithelial / Condition, Lineage and Cell class	MAP1A DNAH2 CFAP53 ALOX15 DRC3	5.12e-05	196	91	5	de7aa31354b019d7321a8ef965d59ce2e8b89276
ToppCell	CV-Moderate-1\|Moderate / Virus stimulation, Condition and Cluster	TRANK1 HELZ2 IFIT5 ISG20 IFIT1	5.12e-05	196	91	5	b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1
ToppCell	Mild\|World / Disease group and Cell class	TRANK1 HELZ2 IFIT5 IFIT1 TRIM38	5.12e-05	196	91	5	5e4ed4a5a437cfa002b92775992a791e27aa4c27
ToppCell	Sepsis-URO-Lymphocyte-T/NK-Treg\|URO / Disease, condition lineage and cell class	PASK SORBS2 PWP2 OSBP2 ISG20	5.12e-05	196	91	5	8812d7365fb2b33feff93782d60776e932499a43
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SORBS2 SPTBN1 CAV2 TMCC3 SOS1	5.24e-05	197	91	5	66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb
ToppCell	COVID_non-vent-Lymphocytic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TRANK1 SPTBN1 ISG20 ATM USP9Y	5.24e-05	197	91	5	c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A IFT172 DNAH2 ALOX15 DRC3	5.24e-05	197	91	5	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	CV-Moderate-1\|CV / Virus stimulation, Condition and Cluster	TRANK1 HELZ2 IFIT5 ISG20 IFIT1	5.24e-05	197	91	5	e3d00d850b4d191f9592ef993c0eaadfe5710b5f
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A IFT172 DNAH2 ALOX15 DRC3	5.24e-05	197	91	5	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	Bronchial_Brush-Epithelial\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	IFT172 SPTBN1 CFAP53 ALOX15 DRC3	5.24e-05	197	91	5	272c7f4e582ef57564450540242b0db766b78328
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A IFT172 DNAH2 ALOX15 DRC3	5.24e-05	197	91	5	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	mild-dn_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TRANK1 SPTBN1 MAEL ISG20 ANKRD45	5.24e-05	197	91	5	07a1f59c83b748825e0708cd1cc7b63a2cb856cc
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A IFT172 DNAH2 ALOX15 DRC3	5.24e-05	197	91	5	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	CV-Severe-1\|Severe / Virus stimulation, Condition and Cluster	HELZ2 IFIT5 ISG20 KIR2DL2 IFIT1	5.37e-05	198	91	5	9b9ee0b0f6cc92e7be94869604c98f43d57ff8ff
ToppCell	severe-Myeloid-Neutrophils_2\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HELZ2 IFIT5 ISG20 IFIT1 TRIM38	5.37e-05	198	91	5	636878836678a0715550fa09f2e3dac11c4d73fe
ToppCell	distal-1-Endothelial-Vein\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SORBS2 NALF1 ABCC8 SPTBN1 CAV2	5.37e-05	198	91	5	eee6cb4fe0e1caf460869d5a0a57c9d259573f10
ToppCell	Control-Control-Lymphocyte-T/NK-CD4+_T_activated\|Control / Disease, condition lineage and cell class	TRANK1 SPTBN1 HELZ2 AKAP11 IFIT1	5.37e-05	198	91	5	ee71543559836fd59adc0da877b2ca538cba60cb
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DLGAP5 POC1B APOBEC3H IFIT1 ALOX15	5.50e-05	199	91	5	f894c88ecc7fd0edca28587801fa59352d10f750
ToppCell	COVID-19_Moderate\|World / disease group, cell group and cell class	TRANK1 SPTBN1 HELZ2 ISG20 IFIT1	5.50e-05	199	91	5	952fac67588ad5676f5939e3c7f8bac803c27064
ToppCell	distal-Epithelial-Ciliated-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IFT172 DNAH2 CFAP53 ALOX15 DRC3	5.50e-05	199	91	5	6ce0df4a6f4d9353919e26ffab97c9ec89911da6
ToppCell	distal-2-Epithelial-Ciliated\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	IFT172 DNAH2 CFAP53 ALOX15 DRC3	5.50e-05	199	91	5	97b66b82c76c7bc1fcd7da7b94dd2aa2d4d70a60
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DLGAP5 POC1B APOBEC3H IFIT1 ALOX15	5.50e-05	199	91	5	2b754670fe77c2301afcdcfc73a1e52cc0cd1de3
ToppCell	LPS_anti-TNF-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ZBTB39 DLGAP5 POC1B MMD ALOX15	5.63e-05	200	91	5	0b02f3ca3d8612ed7af46381195b0ed5591313cf
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SORBS2 SPTBN1 CPLANE1 PPL ALOX15	5.63e-05	200	91	5	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DLGAP5 POC1B APOBEC3H IFIT1 ALOX15	5.63e-05	200	91	5	f100edfd2b3b742458cbbf34de9c403c4d272d3c
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	SIN3B SPTBN1 HELZ2 ELK3 IFIT1	5.63e-05	200	91	5	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DNAH2 ANKMY1 ANKRD45 ECM1 DRC3	5.63e-05	200	91	5	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	TBX15 TLR3 DNAH2 CAV2 TRIM38	5.63e-05	200	91	5	aafe594c88710f8c53d59667cdac5035e08f5511
ToppCell	Biopsy_IPF-Epithelial-Ciliated\|Biopsy_IPF / Sample group, Lineage and Cell type	IFT172 DNAH2 CFAP53 ALOX15 DRC3	5.63e-05	200	91	5	bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8
ToppCell	LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	DLGAP5 POC1B APOBEC3H IFIT1 ALOX15	5.63e-05	200	91	5	fa1eaf008b54bdf7bbcdec8134460c5f64490de9
ToppCell	LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	DLGAP5 POC1B APOBEC3H IFIT1 ALOX15	5.63e-05	200	91	5	f99e214eb680fd82a33f2b1524fbfca265d1cc42
ToppCell	LPS_IL1RA-Hematopoietic_Erythro-Megakary\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	DLGAP5 POC1B APOBEC3H IFIT1 ALOX15	5.63e-05	200	91	5	d85074b362b11e5a523a5325d203a61aa2759a7a
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	TBX15 TLR3 DNAH2 CAV2 TRIM38	5.63e-05	200	91	5	a6f0f5f644b7262878b0b9d4d90ee407c4124dd9
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Severe / Disease, condition lineage and cell class	TRANK1 ISG20 ATM USP9Y IFIT1	5.63e-05	200	91	5	deeed668b129e66156b5f6abe1a07a9bf842a14d
ToppCell	MS-IIF-Lymphocyte-T/NK-dn_T\|IIF / Disease, condition lineage and cell class	SORBS2 SPTBN1 IFT122 ISG20 AAR2	5.63e-05	200	91	5	c34fff02992cba6bcc2308019cb00b94e1227300
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DNAH2 ANKMY1 ANKRD45 ECM1 DRC3	5.63e-05	200	91	5	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell	Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	INTS7 DLGAP5 ZNF692 DRC3	1.34e-04	127	91	4	556aaf88719c83f307fa50dfac151136ed05c8ad
ToppCell	IIF-Lymphocyte-T_NK-dnT\|IIF / Disease, Lineage and Cell Type	SORBS2 SPTBN1 IFT122 ISG20	2.28e-04	146	91	4	d0f361662db5f7be26104346e8431f7e30c5ce3a
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH2 ANKMY1 ANKRD45 DRC3	2.41e-04	148	91	4	d61123f0c811287843d066b932b4a9ff09c07c5b
ToppCell	IIH-CD4-antiviral_CD4\|IIH / Condition, Cell_class and T cell subcluster	HELZ2 MAEL ISG20 IFIT1	2.41e-04	148	91	4	ec626a44cea83f2a0e5c27fc8182f96446d297ac
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH2 ANKMY1 ANKRD45 DRC3	2.41e-04	148	91	4	c8e93b87212f55774223caa385859c566fa1981f
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Vgll3_(Dentate_hilum?)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	WDR87 CYP26A1 USP9Y	2.52e-04	60	91	3	aa75fef294803ec6396c7d2c1f51d52bc4a5b43f
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Vgll3_(Dentate_hilum?)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	WDR87 CYP26A1 USP9Y	2.52e-04	60	91	3	069fbabfd0e48e5809ff01a026439fd0bd017779
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH2 ANKMY1 ANKRD45 DRC3	2.80e-04	154	91	4	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH2 ANKMY1 ANKRD45 DRC3	2.80e-04	154	91	4	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	COVID-CD4-antiviral_CD4\|COVID / Condition, Cell_class and T cell subcluster	PASK IFIT5 ISG20 IFIT1	2.87e-04	155	91	4	7e5ae034036fe85915d38a24195501e6d3bcbfb0
ToppCell	PBMC-Control-cDC_1\|Control / Compartment, Disease Groups and Clusters	TRANK1 HELZ2 IFIT5 IFIT1	2.94e-04	156	91	4	9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-3\|TCGA-Pancreas / Sample_Type by Project: Shred V9	LRRC66 IFT172 DNAH2 ZFPM1	3.09e-04	158	91	4	ec1a71b8f46179642b5af20e27764bb43c4b8e99
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Enterocyte_(Proximal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY10 TRIM38 FCHO1 ALOX15	3.16e-04	159	91	4	709b57f992a29878cc899d760d144d36cb5cb280
ToppCell	TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-2\|TCGA-Mesothelium / Sample_Type by Project: Shred V9	SORBS2 TRANK1 TLR3 IFIT1	3.24e-04	160	91	4	d288b0a315f6adc0be4bdc89fa67bf93679a743f
Disease	Osteoarthritis, Knee	SBNO1 WWP2	5.38e-05	4	89	2	C0409959
Disease	VACTERL association (implicated_via_orthology)	TBC1D32 IFT172	1.34e-04	6	89	2	DOID:14679 (implicated_via_orthology)
Disease	C-reactive protein measurement	HOXB7 TRANK1 MAP1A SBNO1 IFT172 CYP26A1 POC1B YTHDC2 HID1 ZFPM1 CAV2 PPL	2.68e-04	1206	89	12	EFO_0004458
Disease	chronic musculoskeletal pain	WWP2 ECM1	5.82e-04	12	89	2	EFO_0022195
Disease	diastolic blood pressure, systolic blood pressure	TBX15 HOXB4 ANKFY1 DNAH2 ISG20 CPSF3 TMCC3 ALOX15	9.52e-04	670	89	8	EFO_0006335, EFO_0006336
Disease	idiopathic scoliosis (implicated_via_orthology)	MBTPS1 PPP2R3B	1.05e-03	16	89	2	DOID:0060250 (implicated_via_orthology)
Disease	leukemia (implicated_via_orthology)	HOXB4 ATM	1.49e-03	19	89	2	DOID:1240 (implicated_via_orthology)
Disease	serum gamma-glutamyl transferase measurement	SORBS2 TRANK1 MAP1A SBNO1 IFT172 CYP26A1 POC1B ZFPM1 FCHO1	1.76e-03	914	89	9	EFO_0004532
Disease	Prostatic Neoplasms	MBTPS1 PRKDC ATM CAV2 MED12 ZMYM3 PPL	2.63e-03	616	89	7	C0033578
Disease	Malignant neoplasm of prostate	MBTPS1 PRKDC ATM CAV2 MED12 ZMYM3 PPL	2.63e-03	616	89	7	C0376358

Protein segments in the cluster

Peptide	Gene	Start	Entry
LSRELFESWCTDKRN	CPSF3	336	Q9UKF6
ENDLTWVLKHCERFL	TBC1D32	1031	Q96NH3
SSCAWELVDFIKAHD	APOBEC3H	86	Q6NTF7
FEHWKRLLNLLCRSE	AAR2	271	Q9Y312
LSACRAKNEWLETHT	ANKRD45	201	Q5TZF3
LITFEKHDEWLSCAP	CAMTA2	51	O94983
SEERCKSLFDWLLEN	AKAP11	1886	Q9UKA4
DEWEGLRKHDVCFLI	AQR	551	O60306
LWLHEAQRTFCDRLD	DNHD1	2646	Q96M86
KCSLEIHGLFETQEW	ADCY10	121	Q96PN6
CKFWELDTDHDLLID	PPP2R3B	321	Q9Y5P8
STDRLLWREAKLDHC	ISG20	111	Q96AZ6
WLNSLKEFSHAEQCL	INTS7	561	Q9NVH2
ILQCWSDVRFEHFLL	KIR2DS2	46	P43631
CAEIIASHWDDLRKE	ANKFY1	186	Q9P2R3
WEVFRVSSDKLALCH	FCHO1	71	O14526
LDIHRPEDCWNKFIS	COQ2	321	Q96H96
CWLVKDLLHSQRDSA	PASK	926	Q96RG2
ILQCWSDVRFEHFLL	KIR2DL2	46	P43627
KNLLCYDHRTDVWEE	KLHL36	461	Q8N4N3
TWRDKAEHCINDIAF	IFT122	6	Q9HBG6
CFWKLVRHLDRIDSV	MAP1A	71	P78559
TRCKWHEENDILFCA	MAEL	281	Q96JY0
DDSHRQKDCFWLLDA	MBTPS1	851	Q14703
WDDLIALCINHKLRD	MCM3AP	1741	O60318
SLEFHRQLDKVSQWC	MCF2L2	426	Q86YR7
DWKEYLNLLICEESH	PPL	301	O60437
ANTEIHRKDDALWCR	ZFPM1	161	Q8IX07
LLAKCWVRSSDFQLH	ALOX15	341	P16050
FLLNVLDRAWHIKCV	LHX5	16	Q9H2C1
RHEFLTWVLECFEKI	MED12	251	Q93074
LWRTNFDELHCKGLT	POC1B	296	Q8TC44
CRDFLELAEIHSRKW	OSBP2	371	Q969R2
QSKAAEWHCSLRDLE	LRRC66	831	Q68CR7
HLLFDGCNLTRESWK	METTL7A	196	Q9H8H3
SALLHRLSDDCWEKI	MMD	46	Q15546
HSWADLRDVLFNLCE	IFT172	1501	Q9UG01
AHALCLSERQIKIWF	HOXB4	196	P17483
AHTLCLTERQIKIWF	HOXB7	171	P09629
HWIDREKLRNFILAC	RABGGTB	256	P53611
WDQHNDCKILDSLVR	CFAP53	66	Q96M91
NHDIWIKTLTCAFLD	ATM	1801	Q13315
AILLELECHFTWNLL	IFIT5	11	Q13325
LECHFTWNLLKEDID	IFIT5	16	Q13325
ECLKLTFLAIRWHEN	CPLANE1	206	Q9H799
CTDGKLFNHLETIWR	COQ10A	161	Q96MF6
EDSLIQLRCHFTWKL	IFIT1B	11	Q5T764
SHCFEWDRKLELDIP	DLGAP5	446	Q15398
NHEWICRILKDNFAS	ANKMY1	271	Q9P2S6
EEKTILSCILRHFWI	CYP4V2	476	Q6ZWL3
EHLICWTSNDGEFKL	ELK3	21	P41970
FLHNKAEWRCEIEAT	MAP3K20	276	Q9NYL2
KDSLEQLRCHFTWEL	IFIT1	11	P09914
LLKIFTVELARHCDW	CYP26A1	451	O43174
HTNRLECAKLVWEEA	ECM1	226	Q16610
INSWCTRLIDRIHKD	DRC3	476	Q9H069
KLWESFIRECVERHS	HELZ2	926	Q9BYK8
FDKVWICSHALFEIS	CAV2	66	P51636
DWACLIVDEAHRLKN	CHD4	866	Q14839
AFEKDVDHWERCLSL	DNAH2	1421	Q9P225
TRLKQLLHWCGDDFD	SBNO1	416	A3KN83
LFLKCFHWLAEDRVD	SYVN1	111	Q86TM6
LQCFLHEEEKSYLWR	TRIM38	186	O00635
FAVTLLAIFCKNWDH	TMCC3	451	Q9ULS5
LENFSILETHLTWLC	PIGF	31	Q07326
DVSNELRRKIWTCFE	RBL1	811	P28749
QFHQELLVLFWKLCD	HID1	366	Q8IV36
ELQCADLWKRFHDIG	TBX15	116	Q96SF7
RTAICKELDHWTLLQ	SIN3B	416	O75182
RHTTNLTLWFEKCIV	SOS1	826	Q07889
HKDLLRAWSQCSTEE	SORBS2	486	O94875
TQSCADLDKWLHGLE	SPTBN1	1386	Q01082
FQRSECQLFEHWKTL	ABCC8	916	Q09428
QTDDSLIHFCWKDRT	ADRM1	51	Q16186
LIHFCWKDRTSGNVE	ADRM1	56	Q16186
LDLKVWSCHTLRNEL	WWP2	81	O00308
IDDFSFQWLKCLEHL	TLR3	346	O15455
LDEFDRLTHCADWKP	TDRKH	436	Q9Y2W6
HRADFSVLIWDICSK	MIOS	136	Q9NXC5
SIQRHLDDLSKLCSW	PWP2	851	Q15269
WNALETECHSLKREN	SLMAP	666	Q14BN4
VQELCSLKHCEFWLE	PRND	136	Q9UKY0
LREHFEKWGTLTDCV	HNRNPA3	51	P51991
NSEDTIKLLRFCSWE	USP9Y	2296	O00507
TLLWHCSLDALREFF	PRKDC	1826	P78527
FRHNLEIIKTLVECW	PRKDC	2231	P78527
SVCANSFVDWHLLEK	ZBTB39	511	O15060
ACLSDIWLHKDIDAF	YTHDC2	471	Q9H6S0
HLCDRSFTEKWALNN	ZNF407	1631	Q9C0G0
RIWDIVLDHCKLADS	TRANK1	896	O15050
ETNCLRLWKFHDFLS	WDR87	536	Q6ZQQ6
FSRVEEEHLWECKQL	ZMYM3	1186	Q14202
LLSRIKQEEHQCVWD	ZNF282	326	Q9UDV7
EQWCLLKERLGFSLH	ZNF692	36	Q9BU19
CEDCEKIFRWRSHLI	ZNF7	636	P17097
LLSDHLWFCAEAKLT	NALF1	51	B1AL88